• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by Hercules Capital Inc.

    6/11/25 5:22:13 PM ET
    $HTGC
    Investment Managers
    Finance
    Get the next $HTGC alert in real time by email
    FWP 1 d77552dfwp.htm FWP FWP

    Filed pursuant to Rule 433

    Issuer Free Writing Prospectus dated June 11, 2025

    Relating to Preliminary Prospectus Supplement dated June 11, 2025 and

    Prospectus dated December 11, 2024

    Registration No. 333-283735

    Hercules Capital, Inc.

    $350,000,000

    6.000% Notes due 2030

    PRICING TERM SHEET

    June 11, 2025

    The following sets forth the final terms of the 6.000% Notes due 2030 and should only be read together with the preliminary prospectus supplement dated June 11, 2025, together with the accompanying prospectus dated December 11, 2024, relating to these securities (the “Preliminary Prospectus”), and supersedes the information in the Preliminary Prospectus to the extent inconsistent with the information in the Preliminary Prospectus. In all other respects, this pricing term sheet is qualified in its entirety by reference to the Preliminary Prospectus. Terms used herein but not defined herein shall have the respective meanings as set forth in the Preliminary Prospectus. All references to dollar amounts are references to U.S. dollars.

     

    Issuer    Hercules Capital, Inc.
    Issuer Ticker    HTGC
    Security    6.000% Notes due 2030 (the “Notes”)
    Ratings*    Baa3 (Positive) (Moody’s); BBB- (Stable) (Fitch)
    Trade Date    June 11, 2025
    Settlement Date    June 16, 2025 (T+3)
    Aggregate Principal Amount Offered    $350,000,000
    Maturity    June 16, 2030, unless earlier repurchased or redeemed
    Price to Public (Issue Price)    98.907%
    Coupon (Interest Rate)    6.000%
    Yield to Maturity    6.258%
    Spread to Benchmark Treasury    +225 basis points
    Benchmark Treasury    4.000% due May 31, 2030
    Benchmark Treasury Price and Yield    99-30 3⁄4 / 4.008%


    Interest Payment Dates    June 16 and December 16, commencing December 16, 2025
    Optional Redemption    Prior to May 16, 2030 (one month prior to their maturity date) (the “Par Call Date”), we may redeem the Notes at our option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:
      

    (1) (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the Notes matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 35 basis points less (b) interest accrued to, but not including, the date of redemption, and

      

    (2) 100% of the principal amount of the Notes to be redeemed,

       plus, in either case, accrued and unpaid interest thereon to, but not including, the redemption date.
       On or after the Par Call Date, we may redeem the Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but not including, the redemption date.
    Change of Control    Holders have the right to require Hercules Capital, Inc. to repurchase the Notes at 100% of their principal amount plus accrued and unpaid interest, if any, in the event of a change of control repurchase event.
    Denomination    $2,000 and integral multiples of $1,000 in excess thereof
    CUSIP    427096 AN2
    ISIN    US427096AN29
    Joint Book-Running Managers    Goldman Sachs & Co. LLC
    SMBC Nikko Securities America, Inc.
    Co-Managers:   

    MUFG Securities Americas Inc.

     

    Zions Direct, Inc.

     

    RBC Capital Markets, LLC

     

    Synovus Securities, Inc.

     

    Keefe, Bruyette & Woods, Inc.

     

    *

    Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. Each securities rating should be evaluated independent of each other securities rating.

    Hercules Capital, Inc. expects that delivery of the Notes will be made to investors on or about June 16, 2025, which will be the third business day following the date hereof. Under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary market are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade Notes prior to the business day before the delivery of the Notes hereunder will be required, by virtue of the fact that the Notes initially settle in T+3, to specify an alternate settlement arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the Notes who wish to trade the Notes prior to their date of delivery should consult their advisors.

     

    2


    Investors are advised to carefully consider the investment objectives, risks, charges and expenses of Hercules Capital, Inc. before investing. The Preliminary Prospectus, which has been filed with the Securities and Exchange Commission (the “SEC”), contains this and other information about Hercules Capital, Inc. and should be read carefully before investing.

    The information in the Preliminary Prospectus and in this pricing term sheet is not complete and may be changed. The Preliminary Prospectus and this pricing term sheet are not offers to sell any securities of Hercules Capital, Inc. and are not soliciting an offer to buy such securities in any jurisdiction where such offer and sale is not permitted.

    An effective shelf registration statement relating to these securities is on file with the SEC. The offering may be made only by means of a preliminary prospectus supplement and an accompanying prospectus. Copies of the Preliminary Prospectus may be obtained from Goldman Sachs & Co. LLC, 200 West Street, New York, New York 10282, or email [email protected], or telephone: 1-866-471-2526, or SMBC Nikko Securities America, Inc., 277 Park Avenue, New York, New York 10172, or email [email protected], or telephone: 1-212-224-5135.

     

    3

    Get the next $HTGC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HTGC

    DatePrice TargetRatingAnalyst
    12/12/2024$19.50 → $21.50Mkt Perform → Outperform
    Keefe Bruyette
    1/16/2024$17.00 → $17.50Buy → Neutral
    Compass Point
    11/21/2023$17.00Neutral
    UBS
    8/30/2023$17.50Neutral → Buy
    Compass Point
    8/4/2023$13.50 → $17.00Underperform → Mkt Perform
    Keefe Bruyette
    4/6/2023$16.00Neutral → Overweight
    Piper Sandler
    3/13/2023$14.50 → $10.50Mkt Perform → Underperform
    Keefe Bruyette
    7/29/2022Outperform → Perform
    Oppenheimer
    More analyst ratings

    $HTGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer & CCO Botelho Kiersten Zaza covered exercise/tax liability with 770 shares, decreasing direct ownership by 1% to 65,881 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    7/15/25 5:03:48 PM ET
    $HTGC
    Investment Managers
    Finance

    Chief Operating Officer Follmann Christian covered exercise/tax liability with 829 shares, decreasing direct ownership by 0.69% to 119,423 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    7/15/25 5:03:28 PM ET
    $HTGC
    Investment Managers
    Finance

    Chief Financial Officer Meyer Seth H covered exercise/tax liability with 4,051 shares, decreasing direct ownership by 1% to 377,121 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    7/15/25 5:03:12 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hercules Capital Receives a BBB+ Affirmed Investment Grade Corporate and Credit Rating from Kroll Bond Rating Agency, Inc.

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Kroll Bond Rating Agency, Inc. ("KBRA") has affirmed Hercules' investment grade corporate and credit rating of BBB+. KBRA issued a statement announcing the affirmation of the rating and stable outlook, as well as its underlying analysis. The affirmed BBB+ rating reflects the Company's diversified investment portfolio with a focus on senior secured first lien venture debt investments in the technology

    8/19/25 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile

    CARY, N.C., Aug. 8, 2025 Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring designed to enhance the Company's financial flexibility, reduce total debt, and support long-term growth. The multi-faceted refinancing transaction consisted of the following key components: A new senior credit facility with Hercules Capital, Inc. (NYSE:HTGC), due in 2030, which provides $110.0 million in committed capital at closing and an additional $40.0 million in two $20.0 million tranches available upon achievement of certain milestones, to be drawn at the Company's discretion;An exc

    8/8/25 7:45:00 AM ET
    $HRTX
    $HTGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Managers
    Finance

    Snappt Acquires Trigo to Enhance Applicant Trust Platform for Multifamily Housing, Secures $50M Growth Financing

    Strategic growth financing accelerates expansion through acquisition and supports product innovation Snappt, the leading platform for applicant trust in multifamily housing, today announced it has acquired Trigo, a company known for its breakthrough technology in verifying rental payment history. Backed by a $50 million committed facility from Hercules Capital, Inc. (NYSE:HTGC), the acquisition expands Snappt's platform and strengthens its ability to help property managers make faster, more confident leasing decisions. Together, these milestones mark a major step toward building the industry's most complete and trusted solution embedded into the application and screening process. "This

    8/5/25 12:00:00 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Follmann Christian sold $7,043 worth of shares (395 units at $17.83) and bought $7,043 worth of shares (395 units at $17.83), increasing direct ownership by 0.22% to 121,212 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    6/5/25 6:38:34 PM ET
    $HTGC
    Investment Managers
    Finance

    Director Theodosopoulos Nikos bought $104,923 worth of shares (5,999 units at $17.49), increasing direct ownership by 101% to 11,960 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    5/9/25 4:22:23 PM ET
    $HTGC
    Investment Managers
    Finance

    Director Loo Wade bought $104,923 worth of shares (5,999 units at $17.49), returned 5,645 shares to the company and was granted 5,645 shares, increasing direct ownership by 5% to 7,504 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    5/9/25 4:22:04 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hercules Capital upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Hercules Capital from Mkt Perform to Outperform and set a new price target of $21.50 from $19.50 previously

    12/12/24 8:09:58 AM ET
    $HTGC
    Investment Managers
    Finance

    Hercules Capital downgraded by Compass Point with a new price target

    Compass Point downgraded Hercules Capital from Buy to Neutral and set a new price target of $17.50 from $17.00 previously

    1/16/24 8:29:29 AM ET
    $HTGC
    Investment Managers
    Finance

    UBS initiated coverage on Hercules Capital with a new price target

    UBS initiated coverage of Hercules Capital with a rating of Neutral and set a new price target of $17.00

    11/21/23 7:31:43 AM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    SEC Filings

    View All

    Hercules Capital Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - Hercules Capital, Inc. (0001280784) (Filer)

    7/31/25 4:30:57 PM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form 10-Q filed by Hercules Capital Inc.

    10-Q - Hercules Capital, Inc. (0001280784) (Filer)

    7/31/25 4:17:31 PM ET
    $HTGC
    Investment Managers
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Hercules Capital Inc.

    SCHEDULE 13G/A - Hercules Capital, Inc. (0001280784) (Subject)

    7/8/25 2:09:57 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Leadership Updates

    Live Leadership Updates

    View All

    Snappt Acquires Trigo to Enhance Applicant Trust Platform for Multifamily Housing, Secures $50M Growth Financing

    Strategic growth financing accelerates expansion through acquisition and supports product innovation Snappt, the leading platform for applicant trust in multifamily housing, today announced it has acquired Trigo, a company known for its breakthrough technology in verifying rental payment history. Backed by a $50 million committed facility from Hercules Capital, Inc. (NYSE:HTGC), the acquisition expands Snappt's platform and strengthens its ability to help property managers make faster, more confident leasing decisions. Together, these milestones mark a major step toward building the industry's most complete and trusted solution embedded into the application and screening process. "This

    8/5/25 12:00:00 PM ET
    $HTGC
    Investment Managers
    Finance

    Revelation Partners Expands Team with Hire of Andrew Olson, Partner, Chief Financial Officer & Chief Operating Officer

    SAUSALITO, Calif., Nov. 29, 2023 /PRNewswire/ -- Revelation Partners, a healthcare investment firm with over $1.5 billion of capital under management, announced today the addition of Andrew Olson as Partner, Chief Financial Officer and Chief Operating Officer. Mr. Olson has an extensive background in the venture capital and funds management industry. His addition to the team will enhance the firm's technical expertise, support the differentiated investment model, and strengthen the firm's ongoing foundation. As the firm's new Chief Financial Officer and Chief Operating Officer

    11/29/23 1:01:00 PM ET
    $HTGC
    $TPVG
    Investment Managers
    Finance
    Other Consumer Services
    Consumer Discretionary

    Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Nikos Theodosopoulos was appointed to serve as an independent member of its board of directors, effective September 21, 2023. Mr. Theodosopoulos is an experienced corporate executive and board director with more than 38 years in senior management roles in both the financial services and technology industries. Mr. Theodosopoulos will serve on the Company's Audit Committee. "Nikos' combined experienc

    9/25/23 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Financials

    Live finance-specific insights

    View All

    Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile

    CARY, N.C., Aug. 8, 2025 Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring designed to enhance the Company's financial flexibility, reduce total debt, and support long-term growth. The multi-faceted refinancing transaction consisted of the following key components: A new senior credit facility with Hercules Capital, Inc. (NYSE:HTGC), due in 2030, which provides $110.0 million in committed capital at closing and an additional $40.0 million in two $20.0 million tranches available upon achievement of certain milestones, to be drawn at the Company's discretion;An exc

    8/8/25 7:45:00 AM ET
    $HRTX
    $HTGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Managers
    Finance

    Hercules Capital Reports Second Quarter 2025 Financial Results

    Q2 2025 Total Gross Debt and Equity Commitments of $1.0 Billion Record Q2 2025 Total Gross Fundings of $709.1 Million Record 1H 2025 Total Gross Debt and Equity Commitments of $2.02 Billion Record 1H 2025 Total Gross Fundings of $1.25 Billion Record Q2 2025 Net Investment Income "NII" of $88.7 Million Q2 2025 NII of $0.50 per Share provides 125% Coverage of the Base Cash Distribution Closed Upsized Offering of $350.0 Million of 6.000% Unsecured Notes due 2030 Renewed and Increased Its Credit Facility with MUFG Bank, Ltd. to $440.0 Million Conservative Balance Sheet Management with Net GAAP Leverage of 95.0% and Net Regulatory Leverage of 78.7%(1) Inclusive of the Adviser F

    7/31/25 4:07:00 PM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Announces Date for Release of Second Quarter 2025 Financial Results and Conference Call

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2025 financial results conference call for Thursday, July 31, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Resources section of our website at inves

    7/17/25 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Hercules Capital Inc.

    SC 13G - Hercules Capital, Inc. (0001280784) (Subject)

    5/8/23 5:06:26 PM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Hercules Capital Inc. (Amendment)

    SC 13G/A - Hercules Capital, Inc. (0001280784) (Filed by)

    10/12/22 9:11:00 AM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form SC 13G filed by Hercules Capital Inc.

    SC 13G - Hercules Capital, Inc. (0001280784) (Filed by)

    4/27/22 4:31:08 PM ET
    $HTGC
    Investment Managers
    Finance